2.29
0.03 (1.33%)
0.03 (1.33%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entasis Therapeutics Holdings Inc | ETTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.03 | 1.33% | 2.29 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 2.29 | 2.20 | 2.37 | 2.22 | 2.26 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.60 | 2.95 | 1.35 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 683 | 80,239 | $ 2.27 | $ 182,480 | 129,255 | 1.71 - 6.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 1,154 | $ 2.29 | USD |
Entasis Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 81.24M | 35.48M | 28.07M | $ 7.00M | $ - | -3.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 0.10% |
Entasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.97 | 3.03 | 2.20 | 2.60 | 129,960 | -0.68 | -22.9% |
| 1 Month | 2.70 | 3.35 | 2.20 | 2.80 | 159,341 | -0.41 | -15.19% |
| 3 Months | 3.00 | 4.30 | 1.71 | 3.05 | 179,562 | -0.71 | -23.67% |
| 6 Months | 2.60 | 4.30 | 1.71 | 3.01 | 133,040 | -0.31 | -11.92% |
| 1 Year | 6.38 | 6.65 | 1.71 | 3.14 | 74,871 | -4.09 | -64.11% |
| 3 Years | 13.45 | 13.70 | 1.71 | 4.67 | 56,227 | -11.16 | -82.97% |
| 5 Years | 13.45 | 13.70 | 1.71 | 4.67 | 56,227 | -11.16 | -82.97% |
Entasis Therapeutics Description
| Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program. |
